Original Research

Published on 12 Apr 2024

Central venous catheters do not increase the hemorrhagic risk in acute promyelocytic leukemia patients during induction therapy

in Hematologic Malignancies

Manxiong Cao
Jiaqiong Hong
Dongqing Zhang
Feiheng Chen
Yongzhong Su

Frontiers in Oncology

doi 10.3389/fonc.2024.1332372

568 views

Original Research

Published on 11 Apr 2024

Real-world evidence on tagraxofusp for blastic plasmacytoid dendritic cell neoplasm – collected cases from a single center and case reports

in Hematologic Malignancies

Philipp Faustmann
Jan C. Schroeder
Lucas Mix
Lennart Harland
Andreas Riedel
Wichard Vogel
Claudia Lengerke
Stefan Wirths

Frontiers in Oncology

doi 10.3389/fonc.2024.1384172

2,970 views
1 citation

Original Research

Published on 11 Apr 2024

Comparison of cytomorphology and histomorphology in myelodysplastic syndromes

in Hematologic Malignancies

Kathrin Nachtkamp
Corinna Strupp
Rosa Faoro
Norbert Gattermann
Sascha Dietrich
Ulrich Germing
Stefan Baldus

Frontiers in Oncology

doi 10.3389/fonc.2024.1359115

745 views

Case Report

Published on 11 Apr 2024

Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review

in Hematologic Malignancies

Polina Bellman
Jesus D. Gonzalez-Lugo
Moazzam Shahzad
Muhammad Kashif Amin
Muhammad Fareed Khalid
Nahid Suleman
Nausheen Ahmed
Anurag K. Singh
Abdulraheem Yacoub
Da Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1383730

1,618 views

Review

Published on 10 Apr 2024

Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives

in Hematologic Malignancies

Ricardo D. Parrondo
Sikander Ailawadhi
Claudio Cerchione

Frontiers in Oncology

doi 10.3389/fonc.2024.1394048

4,712 views
2 citations

Original Research

Published on 09 Apr 2024

Comparison of chemotherapy and chidamide combined with chemotherapy in patients with untreated angioimmunoblastic T-cell lymphoma

in Hematologic Malignancies

Simeng Gu
Xin Wang
Jingqiu Zhou
Shanshan Du
Ting Niu

Frontiers in Oncology

doi 10.3389/fonc.2024.1373127

815 views

Review

Published on 09 Apr 2024

Targeted therapy for multiple myeloma: an overview on CD138-based strategies

in Hematologic Malignancies

Federico Riccardi
Carmela Tangredi
Michele Dal Bo
Giuseppe Toffoli

Frontiers in Oncology

doi 10.3389/fonc.2024.1370854

3,210 views
4 citations

Systematic Review

Published on 08 Apr 2024

Clinical efficacy and safety of combined anti-BCMA and anti-CD19 CAR-T cell therapy for relapsed/refractory multiple myeloma: a systematic review and meta-analysis

in Hematologic Malignancies

Han Xu
Chaoyang Guan
Peipei Xu
Dongming Zhou
Yong Xu
Bing Chen
Hua Bai

Frontiers in Oncology

doi 10.3389/fonc.2024.1355643

1,969 views
1 citation

Brief Research Report

Published on 08 Apr 2024

Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity

in Hematologic Malignancies

Daria Galas-Filipowicz
Selina J. Chavda
Jia-Nan Gong
David C. S. Huang
Asim Khwaja
Kwee Yong

Frontiers in Oncology

doi 10.3389/fonc.2024.1394393

1,611 views

Original Research

Published on 08 Apr 2024

Genetic prediction of causal association between serum bilirubin and hematologic malignancies: a two-sample Mendelian randomized and bioinformatics study

in Hematologic Malignancies

Lihua Lu
Luting Luo
Xiang Li
Wanying Liu
Boheng Wu
Qing Cai
Jiazheng Li
Yan Huang
Yanxin Chen
Yongzhi Zheng

Frontiers in Oncology

doi 10.3389/fonc.2024.1364834

1,429 views

Mini Review

Published on 04 Apr 2024

Competing risks data in clinical oncology

in Hematologic Malignancies

Haesook Teresa Kim

Frontiers in Oncology

doi 10.3389/fonc.2024.1360266

1,041 views
1 citation

Mini Review

Published on 03 Apr 2024

Diverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: pathogenetic insights and translational implications

in Hematologic Malignancies

Mariusz A. Wasik
Patricia M. Kim
Reza Nejati

Frontiers in Oncology

doi 10.3389/fonc.2024.1383741

966 views
1 citation

Original Research

Published on 03 Apr 2024

IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia

in Hematologic Malignancies

Joaquin Garcia-Solorio
Juan Carlos Núñez-Enriquez
Marco Jiménez-Olivares
Janet Flores-Lujano
Fernanda Flores-Espino
Carolina Molina-Garay
Alejandra Cervera
Diana Casique-Aguirre
José Gabriel Peñaloza-Gonzalez
Ma. Del Rocío Baños-Lara

Frontiers in Oncology

doi 10.3389/fonc.2024.1337954

2,875 views

Original Research

Published on 03 Apr 2024

Analysis of the treatment and prognosis of 266 cases of extranodal natural killer/T-cell lymphoma, nasal type in a single medical center

in Hematologic Malignancies

Lei Yang
Liqiang Wei
Xin Li
Jia Cong
Jin Ye
Na Yao
Jing Yang
Liang Wang
Jingwen Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1388564

973 views

Review

Published on 02 Apr 2024

Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches

in Hematologic Malignancies

Claudia Bozzini
Fabiana Busti
Giacomo Marchi
Alice Vianello
Claudio Cerchione
Giovanni Martinelli
Domenico Girelli

Frontiers in Oncology

doi 10.3389/fonc.2024.1380358

2,323 views
3 citations

Original Research

Published on 28 Mar 2024

CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression

in Hematologic Malignancies

Cristiana Rodrigues
Paula Laranjeira
Aryane Pinho
Isabel Silva
Sandra Silva
Margarida Coucelo
Ana Catarina Oliveira
Ana Teresa Simões
Inês Damásio
Helena Matos Silva

Frontiers in Oncology

doi 10.3389/fonc.2024.1380648

2,235 views
3 citations

Navigation group

Articles

Central venous catheters do not increase the hemorrhagic risk in acute promyelocytic leukemia patients during induction therapy

Real-world evidence on tagraxofusp for blastic plasmacytoid dendritic cell neoplasm – collected cases from a single center and case reports

Comparison of cytomorphology and histomorphology in myelodysplastic syndromes

Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review

Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives

Comparison of chemotherapy and chidamide combined with chemotherapy in patients with untreated angioimmunoblastic T-cell lymphoma

Targeted therapy for multiple myeloma: an overview on CD138-based strategies

Clinical efficacy and safety of combined anti-BCMA and anti-CD19 CAR-T cell therapy for relapsed/refractory multiple myeloma: a systematic review and meta-analysis

Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity

Genetic prediction of causal association between serum bilirubin and hematologic malignancies: a two-sample Mendelian randomized and bioinformatics study

Competing risks data in clinical oncology

Diverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: pathogenetic insights and translational implications

IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia

Analysis of the treatment and prognosis of 266 cases of extranodal natural killer/T-cell lymphoma, nasal type in a single medical center

Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches

CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression